Electrochemical Skin Conductance May Be Used to Screen for Diabetic Cardiac Autonomic Neuropathy in a Chinese Population with Diabetes

Aims. This study aimed to assess whether the electrochemical skin conductance (ESC) could be used to screen for diabetic cardiac autonomic neuropathy (DCAN) in a Chinese population with diabetes. Methods. We recruited 75 patients with type 2 diabetes mellitus (T2DM) and 45 controls without diabetes. DCAN was diagnosed by the cardiovascular autonomic reflex tests (CARTs) as gold standard. In all subjects ESCs of hands and feet were also detected by SUDOSCAN™ as a new screening method. The efficacy was assessed by receiver operating characteristic (ROC) curve analysis. Results. The ESCs of both hands and feet were significantly lower in T2DM patients with DCAN than those without DCAN (67.33 ± 15.37 versus 78.03 ± 13.73, P = 0.002, and 57.77 ± 20.99 versus 75.03 ± 11.41, P < 0.001). The ROC curve analysis showed the areas under the ROC curve were both 0.75 for ESCs of hands and feet in screening DCAN. And the optimal cut-off values of ESCs, sensitivities, and specificities were 76 μS, 76.7%, and 75.6% for hands and 75 μS, 80.0%, and 60.0% for feet, respectively. Conclusions. ESC measurement is a reliable and feasible method to screen DCAN in the Chinese population with diabetes before further diagnosis with CARTs.

[1]  D. Imran,et al.  Early detection of peripheral neuropathy using stimulated skin wrinkling test in human immunodeficiency virus infected patients , 2018, Medicine.

[2]  H. Müderrisoğlu,et al.  Diabetes and cardiac autonomic neuropathy: Clinical manifestations, cardiovascular consequences, diagnosis and treatment. , 2015, World journal of diabetes.

[3]  P. Brunswick,et al.  Noninvasive Galvanic Skin Sensor for Early Diagnosis of Sudomotor Dysfunction: Application to Diabetes , 2012, IEEE Sensors Journal.

[4]  P. Brunswick,et al.  Small fiber neuropathy diagnosis by a non-invasive electrochemical method: mimicking the in-vivo responses by optimization of electrolytic cell parameters , 2014 .

[5]  Linuo Zhou,et al.  Association and Predictive Value Analysis for Resting Heart Rate and Diabetes Mellitus on Cardiovascular Autonomic Neuropathy in General Population , 2014, Journal of diabetes research.

[6]  J. Shaw,et al.  Global and societal implications of the diabetes epidemic , 2001, Nature.

[7]  Jiang He,et al.  Prevalence and control of diabetes in Chinese adults. , 2013, JAMA.

[8]  J. Calvet,et al.  Sudomotor function assessment as a screening tool for microvascular complications in type 2 diabetes. , 2013, Diabetes research and clinical practice.

[9]  P. Low,et al.  Impaired glucose tolerance is associated with postganglionic sudomotor impairment , 2007, Clinical Autonomic Research.

[10]  D. Ewing,et al.  The Value of Cardiovascular Autonomic Function Tests: 10 Years Experience in Diabetes , 1985, Diabetes Care.

[11]  J. Deslypere,et al.  A new non-invasive technology to screen for dysglycaemia including diabetes. , 2010, Diabetes research and clinical practice.

[12]  J. Calvet,et al.  Screening of cardiovascular autonomic neuropathy in patients with diabetes using non-invasive quick and simple assessment of sudomotor function. , 2012, Diabetes & metabolism.

[13]  A. Tahrani,et al.  Cardiac autonomic neuropathy in patients with diabetes mellitus. , 2014, World journal of diabetes.

[14]  Braxton D Mitchell,et al.  The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. , 2003, Diabetes care.

[15]  Rayaz A. Malik,et al.  Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments , 2010, Diabetes Care.

[16]  Barry I. Freedman,et al.  Normative Values for Electrochemical Skin Conductances and Impact of Ethnicity on Quantitative Assessment of Sudomotor Function. , 2016, Diabetes technology & therapeutics.

[17]  A. Vinik,et al.  Sudoscan, a noninvasive tool for detecting diabetic small fiber neuropathy and autonomic dysfunction. , 2013, Diabetes technology & therapeutics.

[18]  P. Low,et al.  Evaluation of sudomotor function , 2004, Clinical Neurophysiology.

[19]  R. Freeman,et al.  Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management , 2011, Diabetes/metabolism research and reviews.

[20]  S. Bornstein,et al.  Assessment of small fiber neuropathy to predict future risk of type 2 diabetes. , 2013, Primary care diabetes.

[21]  A. Goel,et al.  Comparison of electrochemical skin conductance and vibration perception threshold measurement in the detection of early diabetic neuropathy , 2017, PloS one.

[22]  Tao Xu,et al.  A cardiac risk score based on sudomotor function to evaluate cardiovascular autonomic neuropathy in asymptomatic Chinese patients with diabetes mellitus , 2018, PloS one.

[23]  Jasmin Divers,et al.  Relationships between electrochemical skin conductance and kidney disease in Type 2 diabetes. , 2014, Journal of diabetes and its complications.

[24]  Dan Ziegler,et al.  Diabetic neuropathies: a statement by the American Diabetes Association. , 2005, Diabetes care.

[25]  I. Wilkinson,et al.  SUDOSCAN: A Simple, Rapid, and Objective Method with Potential for Screening for Diabetic Peripheral Neuropathy , 2015, PloS one.

[26]  Y. Jang,et al.  Standards of Medical Care in Diabetes-2010 by the American Diabetes Association: Prevention and Management of Cardiovascular Disease , 2010 .

[27]  J. Deslypere,et al.  Quick and Simple Evaluation of Sudomotor Function for Screening of Diabetic Neuropathy , 2012, ISRN endocrinology.

[28]  E. Barrett,et al.  Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. , 2009, JAMA.